Novel Healthcare Approaches for Delirium in Elders
(ENHANCE Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
The Hospital Elder Life Program (HELP), which FAM-HELP is based on, has been shown to effectively prevent delirium in older hospitalized adults, leading to lower rates of delirium, shorter hospital stays, and greater satisfaction among patients and families.
12345The Hospital Elder Life Program (HELP) is generally considered safe for older adults, as it has been successfully implemented in various settings to prevent delirium without reported safety concerns. It is well-received by patients, families, and healthcare staff, and has been shown to improve patient satisfaction and reduce hospital costs.
12467FAM-HELP is unique because it combines the Hospital Elder Life Program (HELP) with family support to prevent delirium in older adults. This approach is novel as it involves family members in the care process, enhancing the traditional HELP model, which focuses on non-drug interventions like orientation, cognitive activities, and sleep promotion.
12489Eligibility Criteria
This trial is for people aged 70 or older who are hospitalized and expected to stay at least 72 hours. They must have a family member available to help, be able to give consent, and have at least one risk factor for delirium but not already be delirious upon admission.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the HELP or FAM-HELP program to prevent delirium during hospitalization
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of cognitive function and delirium burden
Long-term Follow-up
Participants are monitored for hospital readmission and persistent delirium
Participant Groups
FAM-HELP is already approved in United States, Canada, Australia for the following indications:
- Prevention of delirium in older hospitalized adults
- Prevention of delirium in older hospitalized adults
- Prevention of delirium in older hospitalized adults